United Kingdom
Medizinprodukt-Marktintelligenz für United Kingdom. Regulatorische Änderungen, Wettbewerber und Beschaffungstrends.
Neueste Signale
The ALIA device by EASY CARE SOLUTIONS UK LTD is registered as a Class I medical device in EUDAMED.
A new device to measure dark adaptation in AMD patients has been developed, addressing a critical diagnostic need.
SNAP40 device aims to detect patient deterioration in the ED faster than standard monitoring methods.
A study is recruiting to evaluate geko™ device vs standard care for VTE prevention in stroke patients.
The LEAFix device is evaluated for securing airway devices during anesthesia to enhance infection control.
A completed study tested a head-cooling device for temperature reduction on volunteers.
The study on the Watchman FLX device for left atrial appendage closure has been withdrawn.
A study tested rhythmic vibration cues to improve walking in Parkinson's patients with gait freezing.
Mechanical chest compression devices show no survival advantage over manual compressions in recent trials.
A study is recruiting to evaluate a wearable device for continuous lactate monitoring during cardiac surgeries.
The study evaluates the Vicorder device's reliability for measuring pulse wave velocity in chronic stroke patients.
A terminated study evaluated a single-use diagnostic device for respiratory pathogens in adults.
The University of Oxford is recruiting for a study on the VITA device for non-invasive anaemia testing.
The Seismofit device estimates preoperative fitness quickly without heavy exercise, but needs validation in less fit patients.
The ARM-ED study investigates a wearable sensor for detecting respiratory issues in drug toxicity patients.
Eko Health appointed Dr. Steven Steinhubl as CMO to enhance AI-enabled cardiac detection globally.
NHS London is piloting value-based procurement across 13 trusts to enhance medical device acquisition.
AI-embodied surgical robots could enhance surgical practice if ethical and regulatory issues are resolved.
The RebiSmart device aims to improve patient compliance in MS treatment by facilitating self-injection of Rebif.
The study evaluated the accuracy of INR measurements from a LumiraDx device against laboratory methods.